Predicting lewy body pathology in a community-based sample with clinical diagnosis of Alzheimer's disease
- PMID: 17085757
- DOI: 10.1177/0891988706292755
Predicting lewy body pathology in a community-based sample with clinical diagnosis of Alzheimer's disease
Abstract
Accurate antemortem prediction of Lewy body pathology in patients with dementia is problematic. This study generates a model that better predicts Lewy body pathology in community-based patients with clinical Alzheimer's disease. Lewy body pathology was detected in 80 of 152 participants (52.6%) with an initial diagnosis of probable Alzheimer's disease. In a stepwise logistic regression model, female gender, lower education, being married, bradykinesia, hallucinations, and absence of irritability predicted the greatest likelihood of Lewy body pathology. The predictive model correctly diagnosed Lewy body pathology with an estimated sensitivity of 75%, specificity of 68%, and accuracy of 72%; the area under the receiver operating characteristic curve was 0.75. In a community-based autopsy sample, this predictive model confirmed parkinsonism and hallucinations as important predictors of Lewy body pathology in patients with clinical Alzheimer's disease. The model also identified other demographic and clinical characteristics that might enhance the prediction of Lewy body pathology.
Similar articles
-
What best differentiates Lewy body from Alzheimer's disease in early-stage dementia?Brain. 2006 Mar;129(Pt 3):729-35. doi: 10.1093/brain/awh725. Epub 2006 Jan 9. Brain. 2006. PMID: 16401618
-
Reappraisal of a consecutive autopsy series of patients with primary degenerative dementia: Lewy-related pathology.APMIS. 2007 Jul;115(7):820-7. doi: 10.1111/j.1600-0463.2007.apm_521.x. APMIS. 2007. PMID: 17614849
-
Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists.Arch Pathol Lab Med. 1993 Feb;117(2):132-44. Arch Pathol Lab Med. 1993. PMID: 8427562 Review.
-
Depletion or preservation of cardiac sympathetic nerve - an autopsy-verified contrast in two cases of Alzheimer's disease with or without Lewy bodies.Eur Neurol. 2010;64(3):129-33. doi: 10.1159/000316772. Epub 2010 Jul 22. Eur Neurol. 2010. PMID: 20664206
-
Neuropathology of Lewy body disorders.Brain Res Bull. 2009 Oct 28;80(4-5):203-10. doi: 10.1016/j.brainresbull.2009.06.018. Epub 2009 Jul 1. Brain Res Bull. 2009. PMID: 19576266 Review.
Cited by
-
PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders.BMC Neurol. 2014 Apr 9;14:79. doi: 10.1186/1471-2377-14-79. BMC Neurol. 2014. PMID: 24716655 Free PMC article.
-
Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes.Eur J Epidemiol. 2021 Jan;36(1):89-101. doi: 10.1007/s10654-020-00643-2. Epub 2020 May 15. Eur J Epidemiol. 2021. PMID: 32415541 Free PMC article.
-
Prediction of neuropathologic lesions from clinical data.Alzheimers Dement. 2023 Jul;19(7):3005-3018. doi: 10.1002/alz.12921. Epub 2023 Jan 21. Alzheimers Dement. 2023. PMID: 36681388 Free PMC article.
-
Visual hallucinations in dementia: a prospective community-based study with autopsy.Am J Geriatr Psychiatry. 2009 Apr;17(4):317-23. doi: 10.1097/JGP.0b013e3181953b9a. Am J Geriatr Psychiatry. 2009. PMID: 19307860 Free PMC article.
-
Visual hallucinations in Alzheimer's disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas.Alzheimers Res Ther. 2019 Sep 12;11(1):80. doi: 10.1186/s13195-019-0519-7. Alzheimers Res Ther. 2019. PMID: 31511061 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical